The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.
The company received three complaints about patients who had perforation injuries linked to the devices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback